Other mechanisms of resistance mainly include activating key downstream effector molecules for the growth and survival of tumor cells identical to EGFR, also called “bypass” resistance mechanisms, such as amplification of the ERBB2 gene encoding the HER2 protein and the expansion of the MET gene encoding the MET tyrosine kinase receptor [11]. Here, MET is linked to neoplasm.